News

Filter

Current filters:

None

Popular Filters

8401 to 8425 of 8833 results

German pharma counts cost of drug pricing reforms

27-09-2011

Recent government drug pricing reforms have cost the German pharmaceutical industry billions of euros,…

EuropeFinancialPharmaceuticalPricingResearch

Teva buys out partner Kowa’s interest in Japanese JV for $150 million

27-09-2011

Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA), the world’s largest generic drugmaker,…

Asia-PacificGenericsKowa PharmaceuticalsMergers & AcquisitionsTeva Pharmaceutical Industries

Marina Biotech’s intranasal insulin delivery formulations for sale

27-09-2011

A patent portfolio related to rapid-acting intranasal (IN) insulin delivery formulations, which is owned…

DiabetesLicensingMarina BiotechNeurologicalPatentsPharmaceuticalResearch

ALK-Abello reveals progress with Mitizax in Japan and Europe

26-09-2011

Denmark’s ALK-Abello (ALKB: DC) says that its partner, Japanese drugmaker Torii Pharmaceuticals…

Alk-AbelloMitizaxPharmaceuticalResearchRespiratory and PulmonaryTorii Pharma

Medicines Australia starts new Code of Conduct review

26-09-2011

Pharma trade group Medicines Australia has commenced a Review of its Code of Conduct and invites public…

Asia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalRegulation

EMA advisory panel backs Bayer’s Xarelto for AF-related stroke prevention and DVT

26-09-2011

There was more good news for Bayer HealthCare, the pharma unit of Germany’s Bayer AG (BAY: DE),…

BayerCardio-vascularEuropePharmaceuticalRegulationXarelto

US leadership in global biomedical industry vulnerable to international competition

26-09-2011

The USA still holds a commanding position in the biomedical field, but countries across Europe and Asia…

BiotechnologyFinancialNorth AmericaPharmaceuticalResearch

Positive first Phase III trial of an alpha-pharmaceutical, Bayer’s Alpharadin

26-09-2011

Until recently, options for patients with bone metastases from advanced prostate cancer have been very…

AlgetaAlpharadinBayerOncologyPharmaceuticalResearch

Novartis cancer drug imatinib shows efficacy in PAH

26-09-2011

Swiss drug major Novartis (NOVN: VX) yesterday announced new data today at the European Respiratory Society…

ActelionCardio-vascularImatinib MesylateNovartisPharmaceuticalResearchRespiratory and PulmonaryTracleer

PharmAthene awarded 50% profit split on SIGA smallpox drug

25-09-2011

USA-based PharmAthene (NYSE Amex: PIP) last week won a significant decision in its litigation against…

Anti-viralsFinancialLegalNorth AmericaPharmaceuticalPharmAtheneSIGA Technologies

USA’s GPhA calls on “Super Committee” to pursue policies encouraging use of generic drugs

25-09-2011

The US Generic Pharmaceutical Association (GPhA) says it has sent a letter to Co-Chairs Senator Patty…

GenericsNorth AmericaPoliticsRegulation

Sth Africa’s Litha Healthcare teams with Natco for generics marketing in India

25-09-2011

South Africa-based Litha Healthcare Group has signed an exclusive agreement with Indian generic drugmaker…

Asia-PacificFinancialGenericsLitha HealthcareMarkets & MarketingNatco Pharma

Generic erosion to weigh on unipolar depression drug market

25-09-2011

Owing to the generic erosion of blockbuster agents, the unipolar depression drug market - which includes…

GlobalMarkets & MarketingNeurologicalPharmaceutical

EMA recommends restricting use of Sanofi AF drug Multaq, but sees positive benefit-risk in some patients

23-09-2011

There was mixed news for French drug major Sanofi (Euronext: SAN) yesterday, when the European Medicines…

Cardio-vascularEuropeMultaqPharmaceuticalRegulationSanofi

German drug pricing reforms lower health system’s costs, says AVR report

23-09-2011

The multi-year uptrend in drug expenditure by Germany’s health insurers could be ending, according…

EuropeGenericsHealthcarePharmaceuticalPricing

Bristol-Myers teams up with Ambrx for novel biologics programs in diabetes and heart failure

23-09-2011

US drug major Bristol-Myers Squibb (NYSE: BMY) revealed yesterday that it has teamed up with privately-held…

AmbrxBristol-Myers SquibbCardio-vascularDiabetesLicensingPharmaceutical

Use of generic Rx drugs saved US consumers and the health care system $931 billion over past 10 years, study finds

23-09-2011

An independently conducted analysis showing that the use of generic prescription drugs in the USA has…

GenericsMarkets & MarketingNorth AmericaPricing

8401 to 8425 of 8833 results

Back to top